Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,037 | -23,210 | -14,760 | -11,642 | -8,788 |
| Depreciation Amortization | 1,329 | 4,420 | 3,125 | 1,971 | 926 |
| Accounts receivable | 5,227 | -13,545 | -9,561 | -9,265 | -8,270 |
| Other Working Capital | 2,079 | -15,250 | -17,518 | -14,397 | -11,633 |
| Other Operating Activity | -3,995 | 19,675 | 14,574 | 13,179 | 11,104 |
| Operating Cash Flow | $-8,397 | $-27,910 | $-24,140 | $-20,154 | $-16,661 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,530 | -51,181 | -37,613 | 7,024 | 4,354 |
| PPE Investments | -1,643 | -6,490 | -5,330 | -4,289 | -1,771 |
| Other Investing Activity | 0 | 1 | 0 | 0 | 0 |
| Investing Cash Flow | $6,887 | $-57,670 | $-42,943 | $2,735 | $2,583 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -214 | -1,436 | -1,131 | -710 | -294 |
| Common Stock Issued | 154,382 | 94,365 | 94,204 | 76,211 | 2,983 |
| Other Financing Activity | -16 | -69 | -45 | -28 | -14 |
| Financing Cash Flow | $154,152 | $92,860 | $93,028 | $75,473 | $2,675 |
| Beginning Cash Position | 30,978 | 23,690 | 23,697 | 23,697 | 23,697 |
| End Cash Position | 183,620 | 30,970 | 49,642 | 81,751 | 12,294 |
| Net Cash Flow | $152,642 | $7,280 | $25,945 | $58,054 | $-11,403 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,397 | -27,910 | -24,140 | -20,154 | -16,661 |
| Capital Expenditure | -1,643 | -6,495 | -5,330 | -4,289 | -1,771 |
| Free Cash Flow | -10,040 | -34,405 | -29,470 | -24,443 | -18,432 |